Chapin Davis’s Idexx Laboratories IDXX Stock Holding History

Chapin Davis’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,191	Closed	-$5.54M	–	266
2025 Q4	$5.54M	Buy	8,191 +257	+3%	+$175K	1.3%	21
2025 Q3	$5.07M	Buy	+7,934	New	+$4.82M	1.24%	19

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Chapin Davis's IDXX Position: Q1 2026 in Review

Chapin Davis sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 8,191 shares — an estimated $5.54M sold.

Chapin Davis first reported a position in IDXX in Q3 2025 and held it in 2 quarters. The position peaked at $5.54M in Q4 2025. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Chapin Davis reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
Chapin Davis sold 8,191 Idexx Laboratories shares in Q1 2026, an estimated $5.54M.
Chapin Davis first reported a position in Idexx Laboratories in Q3 2025 and held it in 2 quarters.
Chapin Davis's Idexx Laboratories position peaked at $5.54M in Q4 2025.
1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Chapin Davis's 13F filing for Q1 2026, filed 21 Apr 2026.